Target intelligence / Profile preview

Immunoglobulin heavy variable 1-17 (IGHV1-17)

Target
IGHV1-17
Molecular classification
Immunoglobulin heavy chain variable region, Pseudogene
01

Overview

Immunoglobulin heavy variable 1-17 is a gene located within the human immunoglobulin heavy chain locus (chromosome 14) that encodes the variable region of an immunoglobulin heavy chain. IGHV1-17 is classified as a pseudogene, meaning it does not encode a functional, expressed protein product. During B cell development, immunoglobulin heavy chain variable (IGHV), diversity (IGHD), and joining (IGHJ) genes undergo V(D)J recombination to generate the variable domain of the antibody heavy chain, which forms the antigen-binding region of immunoglobulins. The functional diversity of antibodies is critically dependent on the availability of productive IGHV genes; however, IGHV1-17 does not contribute to antibody diversity due to its lack of functional protein expression and is commonly annotated as non-functional[1][6][2].

Other names
1-17PIGHV117IGHV1-17
02

Mechanism of action

None (not a functional protein, thus no mechanism for drug action)

03

Biological functions

None (as a pseudogene, it does not contribute directly to protein functionality or immune response)
04

Disease associations

None specific to IGHV1-17 itself; in general, diversity among immunoglobulin heavy variable genes underpins antibody diversity and the adaptive immune response, but IGHV1-17 does not yield functional products[1][2][6].
05

Safety considerations

None specific to IGHV1-17; pseudogenes generally do not raise safety or therapeutic challenges.
06

Interacting drugs

None (no known drugs interact with or target IGHV1-17)
07

Biomarkers

None specific to IGHV1-17

Beyond the preview

Go deeper on Immunoglobulin heavy variable 1-17 (IGHV1-17).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 1-17 (IGHV1-17).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call